Expertise in
6
conditions

Dr. David B. Badesch

Pulmonary Medicine
University Of Colorado Hospital
1665 Aurora Ct Fl 2, 
Aurora, CO 
Accepting New Patients
Offers Telehealth
Expertise in
6
conditions
University Of Colorado Hospital
1665 Aurora Ct Fl 2, 
Aurora, CO 

Overview

David Badesch is a Pulmonary Medicine provider practicing medicine in Aurora, Colorado.

Dr. Badesch is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Acute Interstitial Pneumonia, Myringotomy, and Lung Transplant.

He is actively involved in clinical research, co-authoring 80 peer reviewed articles and participating in 15 clinical trials. Dr. Badesch is currently accepting new patients.

Specialties

Pulmonary Medicine

Licenses

Internal Medicine in CO

Hospital Affiliations

Uchealth Highlands Ranch Hospital
University Of Colorado Hospital Authority
Medical Center Of The Rockies
Longs Peak Hospital
Parkview Medical Center, Inc

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Denver Health Medical Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Rocky Mountain Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

University of Colorado Hospital
1665 Aurora Ct Fl 2, Aurora, CO 80045

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

14 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Ralinepag to Evaluate Safety and Effects on Exercise Capacity Assessed by CPET in Subjects With WHO Group 1 Pulmonary Hypertension Who Recently Initiated Therapy
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Ralinepag to Evaluate Safety and Effects on Exercise Capacity Assessed by CPET in Subjects With WHO Group 1 Pulmonary Hypertension Who Recently Initiated Therapy
Enrollment Status: Terminated
Publish Date: July 06, 2026
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
Enrollment Status: Completed
Publish Date: June 16, 2026
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Sotatercept When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy in Newly Diagnosed Intermediate- and High-risk PAH Patients
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Sotatercept When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy in Newly Diagnosed Intermediate- and High-risk PAH Patients
Enrollment Status: Terminated
Publish Date: June 08, 2026
Intervention Type: Other, Drug
Study Drug: Sotatercept
Study Phase: Phase 3
ADAPT - A Patient Registry of the Real-world Use of Orenitram®
ADAPT - A Patient Registry of the Real-world Use of Orenitram®
Enrollment Status: Active_not_recruiting
Publish Date: April 02, 2026
Intervention Type: Drug
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Terminated
Publish Date: June 11, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Dose-Ranging Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
A Dose-Ranging Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Completed
Publish Date: June 10, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension
Enrollment Status: Completed
Publish Date: June 04, 2025
Intervention Type: Drug
Study Drug: Rodatristat Ethyl
Study Phase: Phase 2
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Compare the Efficacy and Safety of Sotatercept Versus Placebo When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Compare the Efficacy and Safety of Sotatercept Versus Placebo When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug, Biological
Study Drug: Sotatercept
Study Phase: Phase 3
A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study to Compare the Efficacy and Safety of Sotatercept (ACE-011) Versus Placebo When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH)
A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study to Compare the Efficacy and Safety of Sotatercept (ACE-011) Versus Placebo When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH)
Enrollment Status: Completed
Publish Date: April 19, 2023
Intervention Type: Drug, Other
Study Drug: Sotatercept
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Enrollment Status: Completed
Publish Date: February 21, 2023
Intervention Type: Other, Biological, Drug, Diagnostic test
Study Phase: Phase 2
View 9 Less Clinical Trials

80 Total Publications

Survival Into Adulthood With FOXF1-Associated Pulmonary Vascular Disease After Neonatal Onset.
Survival Into Adulthood With FOXF1-Associated Pulmonary Vascular Disease After Neonatal Onset.
Journal: Pulmonary circulation
Published: June 09, 2026
Similar Doctors
Expertise in
15
conditions
Dr. Jeffrey J. Swigris
Pulmonary Medicine
Expertise in
15
conditions
Dr. Jeffrey J. Swigris
Pulmonary Medicine
Referral may be required

National Jewish Health

1400 Jackson St, 
Denver, CO 
 (5.5 miles away)
303-388-4461
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jeffrey Swigris is a Pulmonary Medicine provider practicing medicine in Denver, Colorado. Dr. Swigris is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Acute Interstitial Pneumonia, Interstitial Lung Disease, Pulmonary Fibrosis, and Idiopathic Pulmonary Fibrosis. Dr. Swigris is currently accepting new patients.

Expertise in
13
conditions
Dr. Michael E. Wechsler
Pulmonary Medicine
Expertise in
13
conditions
Dr. Michael E. Wechsler
Pulmonary Medicine
Referral may be required
Before you request

National Jewish Health

1400 Jackson Street, Pulmonary Medicine 1, Suite A542, 
Denver, CO 
 (5.5 miles away)
303-788-8500
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

National Jewish Health. Dr. Wechsler is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Asthma, Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome), Hypereosinophilic Syndrome, Eosinophilic Asthma, and Endoscopy. Dr. Wechsler is board certified in American Board Of Internal Medicine. Dr. Wechsler is currently accepting new patients.

Expertise in
9
conditions
Dr. Joshua J. Solomon
Pulmonary Medicine
Expertise in
9
conditions
Dr. Joshua J. Solomon
Pulmonary Medicine
Referral may be required

National Jewish Health

1400 Jackson St, 
Denver, CO 
 (5.5 miles away)
303-388-4461
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Joshua Solomon is a Pulmonary Medicine provider practicing medicine in Denver, Colorado. Dr. Solomon is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Rheumatoid Lung Disease, Interstitial Lung Disease, Acute Interstitial Pneumonia, Pulmonary Fibrosis, and Endoscopy. Dr. Solomon is currently accepting new patients.

Frequently Asked Questions about Dr. David B. Badesch

How do I make an appointment with Dr. David B. Badesch?

You can book an appointment with Dr. David B. Badesch by calling their office at 720-848-0000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. David B. Badesch a top-rated expert for Pulmonary Hypertension?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. David B. Badesch is classified as an Elite expert for Pulmonary Hypertension, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. David B. Badesch specialize in?

While Dr. David B. Badesch is a Pulmonary Medicine, they have specific expertise in Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, and Acute Interstitial Pneumonia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pulmonary Medicine.

Does Dr. David B. Badesch participate in research or clinical trials?

Yes. Dr. David B. Badesch has published 80 articles and abstracts on conditions like Pulmonary Hypertension. You can view a list of Dr. David B. Badesch's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. David B. Badesch accept my insurance?

Dr. David B. Badesch accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 720-848-0000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Badesch's expertise for a condition
ConditionClose
View All 12 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile